| Dr Kelly John Holland, MD | |
|
269 Union St, Lynn, MA 01901-1314 | |
| (781) 581-3900 | |
| (781) 598-5024 |
| Full Name | Dr Kelly John Holland |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 16 Years |
| Location | 269 Union St, Lynn, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427210632 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 248464 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Shore Medical Center - | Salem, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lynn Community Health Inc | 0042217507 | 67 |
News Archive
Liwei Chen, MD, PhD, Assistant Professor of Epidemiology at the LSU Health Sciences Center New Orleans School of Public Health, is the lead author of a research paper showing that weight gain and obesity are more linked to an increase in liquid calories, particularly sugar-sweetened beverages, than calories from solid food.
A new study released today offers hope that California may finally be getting a handle on its 30-year battle with childhood obesity, but it also showcases a patchwork of progress that leaves the majority of the state's counties still registering increases in obesity rates among school-age children.
VitalHealth (MGMA Booth #1560) and Mayo Medical Laboratories have entered into a collaboration to offer VitalHealth's Electronic Health Record (EHR) product, including a solution for physician office connectivity, as part of Mayo Medical Laboratories' outreach offering.
Provectus Biopharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that data on its investigational agent PV-10 for intralesional (IL) treatment of solid tumors were featured in two presentations in the Poster Highlights Session, Melanoma/Skin Cancers, on June 2, 2014 during the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, IL.
Hygeia Therapeutics, Inc. announced today the successful completion of a series of preclinical studies for HYG-102, their lead product for the treatment of vulvar and vaginal atrophy (VVA) and age-related skin fragility. HYG-102 is the lead biodegradable estrogenic candidate in a portfolio of 23 similar compounds licensed from the laboratory of Dr. Richard Hochberg of Yale University.
› Verified 7 days ago
| Entity Name | Lynn Community Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013997691 PECOS PAC ID: 0042217507 Enrollment ID: O20061026000348 |
News Archive
Liwei Chen, MD, PhD, Assistant Professor of Epidemiology at the LSU Health Sciences Center New Orleans School of Public Health, is the lead author of a research paper showing that weight gain and obesity are more linked to an increase in liquid calories, particularly sugar-sweetened beverages, than calories from solid food.
A new study released today offers hope that California may finally be getting a handle on its 30-year battle with childhood obesity, but it also showcases a patchwork of progress that leaves the majority of the state's counties still registering increases in obesity rates among school-age children.
VitalHealth (MGMA Booth #1560) and Mayo Medical Laboratories have entered into a collaboration to offer VitalHealth's Electronic Health Record (EHR) product, including a solution for physician office connectivity, as part of Mayo Medical Laboratories' outreach offering.
Provectus Biopharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that data on its investigational agent PV-10 for intralesional (IL) treatment of solid tumors were featured in two presentations in the Poster Highlights Session, Melanoma/Skin Cancers, on June 2, 2014 during the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, IL.
Hygeia Therapeutics, Inc. announced today the successful completion of a series of preclinical studies for HYG-102, their lead product for the treatment of vulvar and vaginal atrophy (VVA) and age-related skin fragility. HYG-102 is the lead biodegradable estrogenic candidate in a portfolio of 23 similar compounds licensed from the laboratory of Dr. Richard Hochberg of Yale University.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kelly John Holland, MD Po Box 526, Lynn Community Health, Lynn, MA 01903 Ph: (781) 581-3900 | Dr Kelly John Holland, MD 269 Union St, Lynn, MA 01901-1314 Ph: (781) 581-3900 |
News Archive
Liwei Chen, MD, PhD, Assistant Professor of Epidemiology at the LSU Health Sciences Center New Orleans School of Public Health, is the lead author of a research paper showing that weight gain and obesity are more linked to an increase in liquid calories, particularly sugar-sweetened beverages, than calories from solid food.
A new study released today offers hope that California may finally be getting a handle on its 30-year battle with childhood obesity, but it also showcases a patchwork of progress that leaves the majority of the state's counties still registering increases in obesity rates among school-age children.
VitalHealth (MGMA Booth #1560) and Mayo Medical Laboratories have entered into a collaboration to offer VitalHealth's Electronic Health Record (EHR) product, including a solution for physician office connectivity, as part of Mayo Medical Laboratories' outreach offering.
Provectus Biopharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that data on its investigational agent PV-10 for intralesional (IL) treatment of solid tumors were featured in two presentations in the Poster Highlights Session, Melanoma/Skin Cancers, on June 2, 2014 during the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, IL.
Hygeia Therapeutics, Inc. announced today the successful completion of a series of preclinical studies for HYG-102, their lead product for the treatment of vulvar and vaginal atrophy (VVA) and age-related skin fragility. HYG-102 is the lead biodegradable estrogenic candidate in a portfolio of 23 similar compounds licensed from the laboratory of Dr. Richard Hochberg of Yale University.
› Verified 7 days ago
Dr. Sarwada Tuladhar Jha, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 269 Union St, Lynn, MA 01901 Phone: 781-581-3900 Fax: 781-598-1050 | |
Walter Spencer Wightman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 269 Union St, Lynn Community Health Inc., Lynn, MA 01901 Phone: 781-581-3900 Fax: 781-598-1050 | |
Patricia A Leblanc, RN Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 269 Union St, Lynn, MA 01901 Phone: 781-581-3900 | |
Ryan Walker, Family Medicine Medicare: Medicare Enrolled Practice Location: 269 Union St, Lynn, MA 01901 Phone: 781-581-3900 | |
Clark Van Den Berghe, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 269 Union St, Lynn, MA 01901 Phone: 781-596-2502 Fax: 781-596-3966 | |
Katherine Louise Rosenfield, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 269 Union St, Lynn, MA 01901 Phone: 781-581-3900 Fax: 781-598-1050 | |
Luis Emilio Velez Velazquez, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 37 Friend St, Lynn, MA 01902 Phone: 978-291-2927 Fax: 781-268-5070 |